Document:

ycbd_ex102

Exhibit 10.2

 

Execution Version

 

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT

 

THIS AMENDED AND RESTATED EXECUTIVE
EMPLOYMENT AGREEMENT (this
“Agreement”)
is made and entered this 19th day of April, 2021 (the
“Effective
Date”) between CBD Industries LLC, a North Carolina
corporation formerly known as cbdMD LLC, whose principal place of
business is 8845 Red Oak Boulevard, Charlotte, NC 28217 (the
“Company”)
and R. Scott Coffman, an individual whose address is 230 S. Tryon,
Charlotte, North Carolina 28202 (the “Executive”).

 

RECITALS

 

WHEREAS, the Company produces and sells
industrial hemp derived consumables and topicals with cannabinoids
(“CBD”)
(the “Business”).

 

WHEREAS, the Company is a wholly-owned
subsidiary of cbdMD, Inc., a North Carolina corporation formerly
known as Level Brands, Inc. (the “Parent”).

 

WHEREAS, the Executive served as a
manager and the principal executive officer of Cure Based
Development, LLC (“Cure”),
an entity acquired by the Parent pursuant to the terms and
conditions of that certain Agreement and Plan of Merger dated
December 3, 2018 (the “Merger
Agreement”) by and among the Parent, AcqCo LLC, the
Company and Cure (the “Mergers”).

 

WHEREAS, pursuant to the term of the
Merger Agreement, at the closing of the Mergers, the Executive was
appointed to the Parent’s Board of Directors (the
“Parent
Board”).

 

WHEREAS, the Company and the Executive
are parties to that certain Executive Employment Agreement dated
December 20, 2018, as amended by Amendment No. 1 to the Executive
Employment Agreement dated November 13, 2020 (collectively, the
“Current Employment
Agreement”).

 

WHEREAS, the Company desires to continue
to employ the Executive and the Executive desires to be employed by
the Company pursuant to the terms of this Agreement.

 

WHEREAS, the Executive, by virtue of the
Executive's employment with the Company, will become familiar with
the manner, methods, trade secrets and other confidential
information pertaining to the Company's business, including the
Company's client base.

 

NOW, THEREFORE, in consideration of the
mutual agreements herein made, the Company and the Executive do
hereby agree as follows:

 

1.           Recitals.
The above recitals are true, correct, and are herein incorporated
by reference.

 

2.           Employment.
The Company hereby agrees to continue to employ the Executive, and
the Executive hereby accepts continued employment with the Company,
upon the terms and conditions hereinafter set forth.

 

 

 

 

3.           Authority
and Power During Employment Period.

 

a.           Duties
and Responsibilities. During the term of this Agreement, the
Executive will serve as (i) Chief Executive Officer of the Company,
and (ii) co-Chief Executive Officer of the Parent, and in these
capacities, shall have such duties and responsibilities consistent
with Executive’s title(s), status, and position as the
Company’s principal executive officer and the co-principal
executive officer of the Parent.

 

b.           Time
Devoted. Throughout the term of the Agreement, the Executive
shall devote substantially all of the Executive's business time and
attention to the business and affairs of the Company consistent
with the Executive's position with the Company, except for
reasonable vacations and except for illness or incapacity, but
nothing in the Agreement shall preclude the Executive from engaging
in a business other than the Business of the Company (as may be
expanded, reduced or otherwise modified from time to time during
the Term) which does not compete with the Company, upon prior
notice to the Audit Committee of the Parent’s Board of
Directors, and provided that such activities do not interfere with
the regular performance of the Executive's duties and
responsibilities under this Agreement.

 

c.           Corporate
Policies. The Executive shall abide by all corporate
governance and employment policies of the Parent and the Company
which may be adopted or modified from time to time including, but
not limited to, the Parent’s insider trading policy, code of
ethics and other corporate governance polities as may be adopted or
modified by the Parent’s Board of Directors from time to
time.

 

4.           Term.
The initial term (“Initial
Term”) of employment hereunder will commence on the
Effective Date and end on December 31, 2023 and may be extended for
additional one (1) year periods (each a “Renewal
Term”) upon mutual consent of the parties by written
consent exchanged at least sixty (60) days before the expiration of
the Initial Term or any Renewal Term, as the case may be, unless
this Agreement shall have been terminated pursuant to Section 6 of
this Agreement. When used herein, ‘Term”
shall mean the Initial Term and any Renewal Term(s).

 

5.           Compensation
and Benefits.

 

a.           Salary.
The Executive shall be paid a base salary (“Base
Salary”), payable in accordance with the Company's
policies from time to time for senior executives, at an annual rate
of (i) Three Hundred Seventy Thousand dollars ($370,000) for the
period commencing on the Effective Date and ending on December 31,
2021, and (ii) Four Hundred Fifty Thousand dollars ($450,000) for
the period commencing on January 1, 2022 and ending on December 31,
2022, and (iii) Five Hundred Thousand dollars ($500,000) for the
period commencing on January 1, 2023 and ending on December 31,
2023.

 

 

2

 

 

(b)           Performance
Bonus Opportunities.

 

(1)           During
the Term, the Executive will be eligible for an annual cash
performance bonus of up to 50% of Executive’s Base Salary
(the “Performance
Bonus”) payable in cash upon the Parent reporting
Total Net Sales equal or exceeding the amount set forth below for
each performance bonus period (“Performance Bonus
Period”) set forth below:

 

	

Performance Bonus Period

	

Minimum Total Net Sales for Performance Bonus Period

	

October
1, 2020 through September 30, 2021

	

$60,000,000

	

October
1, 2021 through September 30, 2022

	

$80,000,000

	

October
1, 2022 through September 30, 2023

	

$100,000,000

 

(2)           For
this purposes of this Agreement, “Total Net
Sales” shall be the Parent’s total net sales as
reported on its consolidated statement of income included in its
consolidated financial statements appearing in its Annual Report on
Form 10-K for year ended, September 30 for the applicable
Performance Bonus Period.

 

(3)           If
the Parent does not report minimum Total Net Sales during one or
more of the Performance Bonus Periods set forth above, the
Executive shall not be entitled to any Performance Bonus for such
period. If the Parent reports Total Net Sales equal to or exceeding
the minimum amount set forth above for the applicable Performance
Bonus Period, then the actual amount of the Performance Bonus for
such Performance Bonus Period shall be determined by the
Compensation, Corporate Governance and Nominating Committee of the
Parent’s Board of Directors, or any successor thereto (the
“Committee”)
in its sole discretion. Such determination shall be made by the
Committee within five business days following the filing by the
Parent of the Annual Report on Form 10-K for the September 30
fiscal year within the applicable Performance Bonus Period. The
payment of a Performance Bonus, if any, shall be made to the
Executive within thirty (30) days of such
determination.

 

c.           Discretionary
Bonus. The Committee shall review the Executive's
performance on an annual basis, and in connection with such annual
review, the Executive may be entitled to receive an annual
discretionary bonus in such amount as may be determined by the
Board of Directors, upon recommendation of the Committee, in its
sole discretion. So long as the Executive is a member of the
Parent’s Board of Directors, he shall abstain from
participation in the deliberations of the Board of Directors in the
establishment of the annual performance goals.

 

d.           Executive
Benefits. The Executive shall be entitled to participate in
all benefit programs of the Company currently existing or hereafter
made available to executive and/or salaried employees including,
but not limited to, stock option plans, pension and other
retirement plans, group life insurance, hospitalization, surgical
and major medical coverage, sick leave, salary continuation,
vacation and holidays, long-term disability, and other fringe
benefits.

 

e.           Vacation.
During each fiscal year of the Company, the Executive shall be
entitled to such amount of vacation consistent with the Executive's
position and length of service to the Company.

 

 

3

 

 

f.           Business
Expense Reimbursement. During the Term of employment, the
Executive shall be entitled to receive proper reimbursement for all
reasonable, out of-pocket expenses incurred by the Executive (in
accordance with the policies and procedures established by the
Parent) in performing services hereunder, provided the Executive
properly accounts therefor.

 

g.           Clawback
Provisions. Notwithstanding any other provisions in this
Agreement to the contrary, any incentive-based compensation, or any
other compensation, paid to the Executive pursuant to this
Agreement or any other agreement or arrangement with the Company
which is subject to recovery under any law, government regulation
or stock exchange listing requirement of the Parent, will be
subject to such deductions and clawback as may be required to be
made pursuant to such law, government regulation or stock exchange
listing requirement (or any policy adopted by the Company and/or
the Parent pursuant to any such law, government regulation or stock
exchange listing requirement).

 

h.           Employment
Taxes. All of Executive’s compensation payable
hereunder shall be subject to customary withholding taxes and any
other employment taxes as are commonly required to be collected or
withheld by the Company.

 

6.           Termination.

 

a.           Death.
This Agreement will terminate upon the death of the
Executive.

 

b.           Disability.

 

(1)           The
Executive's employment will terminate in the event of his
disability, upon the first day of the month following the
determination of disability as provided below. Following such a
termination, the Executive shall be entitled to compensation in
accordance with the Company's disability compensation practice for
senior executives, including any separate arrangement or policy
covering the Executive, but in all events the Executive shall
continue to receive his Base Salary, at the annual rate in effect
immediately prior to the commencement of disability, for three (3)
months after the termination. Any amounts provided for in this
Section 6b shall not be offset by other long-term disability
benefits provided to the Executive by the Company or Social
Security.

 

(2)           “Disability,”
for the purposes of this Agreement, shall be deemed to have
occurred if (A) the Executive is unable, by reason of a physical or
mental condition, to perform his duties under this Agreement for an
aggregate of ninety (90) days in any 12-month period or (B) the
Executive has a guardian of the person or estate appointed by a
court of competent jurisdiction. Anything herein to the contrary
notwithstanding, if, following a termination of employment due to
disability, the Executive becomes re-employed, whether as an
executive or a consultant, any compensation, annual incentive
payments or other benefits earned by the Executive from such
employment shall be offset against any compensation continuation
due to the Executive hereunder.

 

 

4

 

 

c.           Termination
by the Company For Cause.

 

(1)           Nothing
herein shall prevent the Company from terminating Executive for
Cause, as hereinafter defined. The Executive shall continue to
receive compensation only for the period ending with the date of
such termination as provided in this Section 6c. Any rights and
benefits the Executive may have in respect of any other
compensation shall be determined in accordance with the terms of
such other compensation arrangements or such plans or
programs.

 

(2)           “Cause”
shall mean (A) committing or participating in an injurious act of
fraud, gross neglect or misrepresentation, embezzlement or
dishonesty against the Company; (B) committing or participating in
any other injurious act or omission wantonly, willfully, recklessly
or in a manner which was grossly negligent against the Company; (C)
engaging in a criminal enterprise involving moral turpitude; (D)
conviction for a felony under the laws of the United States or any
state thereof; (E) violation of any Federal or state securities
laws, rules or regulations, or any rules or regulations of any
stock exchange or other market on which the Parent's securities may
be listed or quoted for trading; (F) violation of the
Parent’s and/or the Company's corporate governance policies;
or (G) any assignment of this Agreement in violation of Section 14
of this Agreement.

 

(3)           Notwithstanding
anything else contained in this Agreement, this Agreement will not
be deemed to have been terminated for Cause unless and until there
shall have been delivered to the Executive a notice of termination
stating that the Executive committed one of the types of conduct
set forth in Section 6c(2) of this Agreement and specifying the
particulars thereof and the Executive shall be given a thirty (30)
day period to cure such conduct set forth in Section
6c(2).

 

d.           Voluntary
Termination. If the Executive terminates the Executive's
employment on the Executive's own volition prior to the expiration
of the Term of this Agreement, including any renewals thereof, such
termination shall constitute a voluntary termination and in such
event the Executive shall be limited to the same rights and
benefits as provided in connection with a termination for Cause as
provided in Section 6c.

 

7.           Covenant
Not To Compete and Non-Disclosure of
Information.

 

a.           Covenant
Not To Compete. The Executive acknowledges and recognizes
the highly competitive nature of the Company's Business and the
goodwill, continued patronage, and the names and addresses of the
Company's Clients (as hereinafter defined) constitute a substantial
asset of the Company having been acquired through considerable
time, money and effort. Accordingly, in consideration of the
execution of this Agreement, and as except as may specifically
otherwise approved by the Parent Board, the Executive agrees to the
following:

 

 

 

5

 

(1)           That
during the Restricted Period (as hereinafter defined) and within
the Restricted Area (as hereinafter defined), the Executive will
not, individually or in conjunction with others, directly or
indirectly, engage in any Business Activities (as hereinafter
defined), whether as an officer, director, proprietor, employer,
partner, independent contractor, investor (other than as a holder
solely as an investment of less than four and ninety-nine one
hundreds percent (4.99%) of the outstanding capital stock of a
publicly traded company), consultant, advisor, agent or
otherwise.

 

(2)           That
during the Restricted Period and within the Restricted Area, the
Executive will not, directly or indirectly, compete with the
Company by soliciting, inducing or influencing any of the Company's
Clients which have a business relationship with the Company at the
time during the Restricted Period to discontinue or reduce the
extent of such relationship with the Company.

 

(3)           That
during the Restricted Period and within the Restricted Area, the
Executive will not (A) directly or indirectly recruit, solicit or
otherwise influence any employee or agent of the Company to
discontinue such employment or agency relationship with the
Company, or (B) employ or seek to employ, or cause or permit any
business which competes directly or indirectly with the Business
Activities of the Company (the “Competitive
Business”) to employ or seek to employ for any
Competitive Business any person who is then (or was at any time
within two (2) years prior to the date Executive or the Competitive
Business employs or seeks to employ such person) employed by the
Company.

 

b.           Non-Disclosure
of Information. The Executive acknowledges that the
Company's trade secrets, private or secret processes, methods and
ideas, as they exist from time to time, customer lists and
information concerning the Company's sources, products, services,
pricing, formula, training methods, development, technical
information, marketing activities and procedures, credit and
financial data concerning the Company and/or the Company's Clients,
and (the “Proprietary
Information”) are valuable, special and unique assets
of the Company, access to and knowledge of which are essential to
the performance of the Executive hereunder. In light of the highly
competitive nature of the industry in which the Company's Business
is conducted, the Executive agrees that all Proprietary
Information, heretofore or in the future obtained by the Executive
as a result of the Executive's association with the Company shall
be considered confidential.

 

In
recognition of this fact, the Executive agrees that the Executive,
during the Restricted Period, will not use or disclose any of such
Proprietary Information for the Executive's own purposes or for the
benefit of any person or other entity or organization (except the
Company) under any circumstances unless such Proprietary
Information has been publicly disclosed generally or, unless upon
written advice of legal counsel reasonably satisfactory to the
Company, the Executive is legally required to disclose such
Proprietary Information. Documents (as hereinafter defined)
prepared by the Executive or that come into the Executive's
possession during the Executive's association with the Company are
and remain the property of the Company, and when this Agreement
terminates, such Documents shall be returned to the Company at the
Company's principal place of business, as provided in the Notice
provision (Section 10) of this Agreement.

 

 

6

 

 

c.           Documents.
“Documents”
shall mean all original written, recorded, or graphic matters
whatsoever, and any and all copies thereof, including, but not
limited to: papers; books; records; tangible things;
correspondence; communications; telex messages; memoranda;
work-papers; reports; affidavits; statements; formulas; summaries;
analyses; evaluations; client records and information; agreements;
agendas; advertisements; instructions; charges; manuals; brochures;
publications; directories; industry lists; schedules; price lists;
client lists; statistical records; training manuals; computer
printouts; books of account, records and invoices reflecting
business operations; all things similar to any of the foregoing
however denominated. In all cases where originals are not
available, the term “Documents” shall also mean
identical copies of original documents or non-identical copies
thereof.

 

d.           Company's
Clients. The “Company's
Clients” shall be deemed to be any persons,
partnerships, companies, professional associations or other
organizations for or with whom
the Company or Cure, prior to the Mergers, has performed Business
Activities, including, but not limited
to, suppliers or vendors with whom the Company or Cure, prior to
the Mergers, has done or is endeavoring to do
business.

 

e.           Restrictive
Period. The “Restrictive
Period” shall be deemed to be one (1) year following
termination of this Agreement.

 

f.           Restricted
Area. The “Restricted
Area” shall be deemed to mean the United
States.

 

g.           Business
Activities. “Business
Activities” shall be deemed to include the Business,
and any additional activities which the Company or any of its
affiliates may engage in during any
portion of the twelve (12) months prior to the termination
of Executive's employment.

 

h.           Covenants
as Essential Elements of this Agreement. It is understood by
and between the parties hereto that the foregoing covenants
contained in Sections 7a and b are essential elements of this
Agreement, and that but for the agreement by the Executive to
comply with such covenants, the Company would not have agreed to
enter into this Agreement. Such covenants by the Executive shall be
construed to be agreements independent of any other provisions of
this Agreement. The existence of any other claim or cause of
action, whether predicated on any other provision in this
Agreement, or otherwise, as a result of the relationship between
the parties shall not constitute a defense to the enforcement of
such covenants against the Executive. To
the extent that the covenants contained in this Section 7 may later
be deemed by a court to be too broad to be enforced with respect to
their duration or with respect to any particular activity or
geographic area, the court making such determination shall have the
power to reduce the duration or scope of the provision, and to add
or delete specific words or phrases to or from the provision. The
provision as modified shall then be enforced.

 

i.           Survival
After Termination of Agreement. Notwithstanding anything to
the contrary contained in this Agreement, the covenants in Sections
7a and b shall survive the termination of this Agreement and the
Executive's employment with the Company.

 

 

7

 

 

j.           Remedies.

 

(1)           The
Executive acknowledges and agrees that the Company's remedy at law
for a breach or threatened breach of any of the provisions of
Section 7a or b herein would be inadequate and the breach shall be
per se deemed as causing irreparable harm to the Company. In
recognition of this fact, in the event of a breach by the Executive
of any of the provisions of Section 7a or b, the Executive agrees
that, in addition to any remedy at law available to the Company,
including, but not limited to monetary damages, all rights of the
Executive to payment or otherwise under this Agreement and all
amounts then or thereafter due to the Executive from the Company
under this Agreement may be terminated and the Company, without
posting any bond, shall be entitled to obtain, and the Executive
agrees not to oppose the Company's request for equitable relief in
the form of specific performance, temporary restraining order,
temporary or permanent injunction or any other equitable remedy
which may then be available to the Company.

 

(2)           The
Executive acknowledges that the granting of a temporary injunction,
temporary restraining order or permanent injunction merely
prohibiting the use of Proprietary Information would not be an
adequate remedy upon breach or threatened breach of Section 7a or b
and consequently agrees, upon proof of any such breach, to the
granting of injunctive relief prohibiting any form of competition
with the Company. Nothing herein contained shall be construed as
prohibiting the Company from pursuing any other remedies available
to it for such breach or threatened breach.

 

8.           Indemnification.
The Executive shall be covered by the Articles of Organization and
Operating Agreement of the Company with respect to matters
occurring on or prior to the date of termination of the Executive's
employment with the Company, subject to all the provisions of North
Carolina and Federal law, the Articles of Organization the Company
and the Operating Agreement of the Company then in effect. Such
reasonable expenses, including attorneys' fees, that may be covered
by these indemnification provisions shall be paid by the Company on
a current basis in accordance with such provision, the Company's
Articles of Organization, Operating Agreement and North Carolina
law. To the extent that any such payments by the Company pursuant
to these provisions may be subject to repayment by the Executive
pursuant to the provisions of the Articles of Organization and/or
Operating Agreement, or pursuant to North Carolina or Federal law,
such repayment shall be due and payable by the Executive to the
Company within twelve (12) months after the termination of all
proceedings, if any, which relate to such repayment and to the
Company's affairs for the period prior to the date of termination
of the Executive's employment with the Company and as to which
Executive has been covered by such applicable
provisions.

 

9.           Withholding.
Anything to the contrary notwithstanding, all payments required to
be made by the Company hereunder to the Executive or the
Executive's estate or beneficiaries shall be subject to the
withholding of such amounts, if any, relating to tax and other
payroll deductions as the Company may reasonably determine it
should withhold pursuant to any applicable law or regulation. In
lieu of withholding such amounts, the Company may accept other
arrangements pursuant to which it is satisfied that such tax and
other payroll obligations will be satisfied in a manner complying
with applicable law or regulation.

 

 

8

 

 

10.           Notices.
Any notice required or permitted to be given under the terms of
this Agreement shall be sufficient if in writing and if sent
postage prepaid by registered or certified mail, return receipt
requested; by overnight delivery; by courier; or by confirmed
telecopy, in the case of the Executive to the Executive's last
place of business or residence as shown on the records of the
Company, or in the case of the Company to its principal office as
set forth in the first paragraph of this Agreement, or at such
other place as it may designate.

 

11.           Waiver.
Unless agreed in writing, the failure of either party, at any time,
to require performance by the other of any provisions hereunder
shall not affect its right thereafter to enforce the same, nor
shall a waiver by either party of any breach of any provision
hereof be taken or held to be a waiver of any other preceding or
succeeding breach of any term or provision of this Agreement. No
extension of time for the performance of any obligation or act
shall be deemed to be an extension of time for the performance of
any other obligation or act hereunder.

 

12.           Completeness
and Modification. This Agreement constitutes the entire
understanding between the parties hereto superseding all prior and
contemporaneous agreements or understandings among the parties
hereto concerning the Agreement. This Agreement may be amended,
modified, superseded or canceled, and any of the terms, covenants,
representations, warranties or conditions hereof may be waived,
only by a written instrument executed by the parties or, in the
case of a waiver, by the party to be charged.

 

13.           Counterparts.
This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original but all of which shall constitute
but one agreement.

 

14.           Binding
Effect/Assignment. This Agreement shall be binding upon the
parties hereto, their heirs, legal representatives, successors and
assigns. This Agreement shall not be assignable by the Executive
but shall be assignable by the Company in connection with the sale,
transfer or other disposition of its business or to any of the
Company's affiliates controlled by or under common control with the
Company.

 

15.           Governing
Law. This Agreement shall become valid when executed and
accepted by the Company. The parties agree that it shall be deemed
made and entered into in the State of North Carolina and shall be
governed and construed under and in accordance with the laws of the
State of North Carolina. Anything in this Agreement to the contrary
notwithstanding, the Executive shall conduct the Executive's
business in a lawful manner and faithfully comply with applicable
laws or regulations of the state, city or other political
subdivision in which the Executive is located.

 

16.           Further
Assurances. All parties hereto shall execute and deliver
such other instruments and do such other acts as may be necessary
to carry out the intent and purposes of this
Agreement.

 

17.           Headings.
The headings of the sections are for convenience only and shall not
control or affect the meaning or construction or limit the scope or
intent of any of the provisions of this Agreement.

 

 

9

 

 

18.           Survival.
Any termination of this Agreement shall not, however, affect the
ongoing provisions of this Agreement which shall survive such
termination in accordance with their terms.

 

19.           Severability.
The invalidity or unenforceability, in whole or in part, of any
covenant, promise or undertaking, or any section, subsection,
paragraph, sentence, clause, phrase or word or of any provision of
this Agreement shall not affect the validity or enforceability of
the remaining portions thereof.

 

20.           Enforcement.
Should it become necessary for any party to institute legal action
to enforce the terms and conditions of this Agreement, the
successful party will be awarded reasonable attorneys' fees at all
trial and appellate levels, expenses and costs.

 

21.           Venue.
The Company and Executive acknowledge and agree that the U.S.
District Court for the State of North Carolina, or if such court
lacks jurisdiction, the State of North Carolina(or its successor)
in and for Mecklenburg County, North Carolina, shall be the venue
and exclusive proper forum in which to adjudicate any case or
controversy arising either, directly or indirectly, under or in
connection with this Agreement and the parties further agree that,
in the event of litigation arising out of or in connection with
this Agreement in these courts, they will not contest or challenge
the jurisdiction or venue of these courts.

 

22.           Construction.
This Agreement shall be construed within the fair meaning of each
of its terms and not against the party drafting the
document.

 

23.           Role
of Counsel. The Executive acknowledges his understanding
that this Agreement was prepared at the request of the Company by
Pearlman Law Group LLP, its counsel, and that such firm did not
represent the Executive in conjunction with this Agreement or any
of the related transactions. The Executive, as further evidenced by
his signature below, acknowledges that he has had the opportunity
to obtain the advice of independent counsel of his choosing prior
to his execution of this Agreement and that he has availed himself
of this opportunity to the extent he deemed necessary and
advisable.

 

THE EXECUTIVE ACKNOWLEDGES THAT THE EXECUTIVE HAS READ ALL OF THE
TERMS OF THIS AGREEMENT, UNDERSTANDS THE AGREEMENT, AND AGREES TO
ABIDE BY ITS TERMS AND CONDITIONS.

 

[signature
page follows]

 

 

10

 

 

IN WITNESS WHEREOF, the parties have
executed this Agreement as of the Effective Date.

 

	

Witness:

	
THE CORPORATION

	

 

	

 

	
 

	

 

	
_____________________________	CBD
Industries LLC	

 

	
 	 	

 

	
_____________________________	By cbdMD,
Inc.,
	

 

	
 	Manager	

 

	

 

	

 

	

 

	

 

	

	
By:  

	
/s/ T. Ronan
Kennedy

	

 

	

 

	

 

	
T. Ronan
Kennedy 

	

 

	

 

	

 

	

Chief Financial
Officer and 

Chief Operating
Officer

	

 

 

 

	
Witness:	
THE
EXECUTIVE

	

 

	

 

	

 

	

 

	

 

	
_____________________________	
By:  

	
/s/ R. Scott
Coffman

	

 

	_____________________________	

 

	
R. Scott
Coffman

	

 

	
	
	
	

 

  

  

 

11EX-4.1

 EXHIBIT 4.1 

SECOND SUPPLEMENTAL INDENTURE 

between 
 FEDNAT HOLDING COMPANY

 and 
 THE BANK OF NEW YORK
MELLON, 
 as Trustee 
 Dated as
of April 19, 2021 
 to the 

INDENTURE 
 Dated as of
March 5, 2019, 
 As amended by the First Supplemental Indenture dated as of March 5, 2020 

 

 SECOND SUPPLEMENTAL INDENTURE 

THIS SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of April 19, 2021 (the “Second
Supplemental Indenture Effective Date”), is between FedNat Holding Company, a Florida corporation (the “Company”), and The Bank of New York Mellon, as trustee (the “Trustee”). 

RECITALS OF THE COMPANY 

WHEREAS, the Company and the Trustee have executed and delivered an Indenture, dated as of March 5, 2019, as amended by the First
Supplemental Indenture dated as of March 5, 2020 (together, the “Indenture”), pursuant to which the Company issued its Senior Unsecured Notes due 2029 (the “Notes”); 

WHEREAS, pursuant to Section 9.2 of the Indenture, the Company may, with the written consent of the Holders of a majority in principal
amount of the Notes then outstanding (the “Requisite Holders”), enter into a supplemental indenture to amend the terms of the Indenture in a manner permitted by such Section 9.2; 

WHEREAS, the Company desires to amend the Indenture to permit the Company to issue additional debt securities and, accordingly, desires to
amend Sections 3.3 and 3.4 as set forth herein; 
 WHEREAS, in consideration of the approval by the Requisite Holders of the amendments to
the Indenture as set forth in this Second Supplemental Indenture, the Company has agreed that the Interest Rate on the Notes shall be increased from 7.50% to 7.75% per annum, effective beginning on March 15, 2021; 

WHEREAS, pursuant to Sections 9.2 and 9.5 of the Indenture, the parties hereto, having the approval of the Requisite Holders (as evidenced by
that certain Confirmation of Consents Certificate of Global Bondholder Services, as tabulation agent, dated April 19, 2021), are authorized to execute and deliver this Second Supplemental Indenture to amend the Indenture; and 

WHEREAS, the Company has duly authorized the execution and delivery of this Second Supplemental Indenture, and all acts and things necessary
to make this Second Supplemental Indenture a valid, binding and legal obligation of the Company and to constitute a valid agreement of the Company, in accordance with its terms, have been done and performed. 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged,
the Company and the Trustee mutually covenant and agree for the benefit of the Holders of the Notes as follows: 
 1. Defined
Terms. As used in this Second Supplemental Indenture, terms defined in the Indenture or in the preamble or recitals hereto are used herein as so defined. 

2. Amendments to the Indenture. The Indenture is hereby amended as follows. 

The defined term “Interest Rate” is hereby replaced in its entirety with the following: 

“Interest Rate” means, beginning on March 15, 2021, a per annum rate equal to (a) 7.75% for each Interest
Accrual Period for which a Step-up Event is not in effect at all times during such Interest Accrual Period; or (b) for each Interest Accrual Period for which a
Step-up Event is in effect at any point during such Interest Accrual Period, 7.75% plus an additional 50 basis points for each notch downgrade of the Company below
“BBB-” (or its equivalent rating) by the Applicable Rating Agency. 

  
 1 

 Section 3.3(a) of the Indenture, “Limitation on Indebtedness,” is hereby
replaced in its entirety with the following: 
 “(a) The Company shall not, and shall not permit any of its Subsidiaries to,
directly or indirectly, Incur any Indebtedness (including Acquired Indebtedness) unless (a) no Event of Default is continuing and (b) the Debt to Capital Ratio of the Company as of the balance sheet date immediately preceding the date on
which such additional Indebtedness is incurred would have been no greater than 60%, determined on a pro forma basis (including a pro forma application of the net proceeds therefrom) as if the additional Indebtedness and all other Indebtedness
incurred since the immediately preceding balance sheet date had been incurred, except to the extent such Indebtedness is used to prepay other Indebtedness and the proceeds therefrom applied as of such day.” 

Section 3.4 of the Indenture, “Limitation on Restricted Payments,” is hereby replaced in its entirety with the following:

 “SECTION 3.4. Limitation on Restricted Payments. The Company shall not, and shall not permit any of its
Subsidiaries to, directly or indirectly: 
 (a) declare or pay any dividend on or in respect of, its Capital Stock or
purchase, redeem, retire or otherwise acquire for value any Capital Stock of the Company (other than wholly in exchange for Capital Stock of the Company (other than Disqualified Stock)); or 

(b) make any payment or other distribution on any other securities of the Company or any of its Subsidiaries that rank junior
to the Notes, including on any Indebtedness of the Company or any of its Subsidiaries (all such payments and other actions under (a) and (b), a “Restricted Payment”); unless, with respect to either clause (a) or
clause (b), at the time of, and after giving effect to such Restricted Payment on a pro forma basis, 
 (i) no Default
shall have occurred and be continuing (or would reasonably be expected to result therefrom); and 
 (ii) the Company’s
Debt to Capital Ratio would be less than 20%.” 
 3. Governing Law; Jurisdiction. THIS SECOND SUPPLEMENTAL INDENTURE SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICTS OF LAWS PROVISIONS THEREOF THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION). THE PARTIES HERETO AGREE TO SUBMIT TO
THE JURISDICTION OF ANY UNITED STATES FEDERAL OR STATE COURT LOCATED IN THE BOROUGH OF MANHATTAN, IN THE CITY OF NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS SECOND SUPPLEMENTAL INDENTURE. 

4. Headings, Etc. The headings of this Second Supplemental Indenture have been inserted for convenience of reference only, are not to
be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 
 5. Execution in
Counterparts. This Second Supplemental Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. Delivery of an executed
counterpart by facsimile, “portable document format” (pdf) or any other electronic means shall be effective as delivery of a manually executed counterpart thereof. 

6. Severability. In the event any provision of this Second Supplemental Indenture shall be invalid, illegal or unenforceable, then (to
the extent permitted by law) the validity, legality or enforceability of the remaining provisions shall not in any way be affected or impaired. 

7. Waiver of Jury Trial. EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SECOND SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY. 

  
 2 

 8. Concerning the Trustee. The Trustee makes no representation as to and shall not be
responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Second Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company. All of the
provisions contained in the Indenture in respect of the rights, powers, privileges, and immunities of the Trustee shall be applicable in respect of this Second Supplemental Indenture as fully and with like force and effect as though fully set forth
in full herein. The Trustee shall not be accountable for the use or application by the Company of the Notes or the proceeds thereof. 

[Remainder of page intentionally left blank]

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the date first written above. 
  

			
	FEDNAT HOLDING COMPANY
		
	By:	 	/s/ Ronald A. Jordan
		 	Name: Ronald A. Jordan
		 	Title: Chief Financial Officer

  

			
	THE BANK OF NEW YORK MELLON, as Trustee
		
	By:	 	/s/ Shannon Matthews
		 	Name: Shannon Matthews
		 	Title: Agent

  
 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]